Prestige Consumer Healthcare Inc. (PBH)
Pharmaceutical Preparations
Latest Price
$46.68
TTM P/E
13.08
Normalized P/E
16.40
Div Yield
--
Book Value
40.38
P/B Ratio
1.16
Valuation metrics
adjust assumptions →EPS: $3.91
Book value / share: $38.74
Formula: √(22.5 × EPS × BVPS)
Graham Number
$58.38
+25% upside
Norm. op. income: $309M (median of 7yr)
Tax rate: 24%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$28.97
38% downside
Base FCF: $243M (median of recent 5yr)
Growth: 3%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$57.05
+22% upside
EPS: $3.91
Target P/E: 16×
Formula: EPS × P/E
P/E Fair Value
$62.56
+34% upside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.83M | $370.0M | 16.50% | +442.8K | 2026-06-30 |
| ARIEL INVESTMENTS, LLC | 4.87M | $230.0M | 10.26% | +594.4K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.83M | $133.0M | 5.95% | +21.5K | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 2.66M | $125.0M | 5.61% | -11.5K | 2026-06-30 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.33M | $110.0M | 4.91% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.14M | $101.0M | 4.50% | +44.0K | 2026-06-30 |
| STATE STREET CORP | 2.12M | $100.0M | 4.46% | +145.5K | 2026-06-30 |
| BRANDES INVESTMENT PARTNERS, LP | 2.05M | $96.0M | 4.32% | +1.20M | 2026-06-30 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1.87M | $88.0M | 3.94% | -330.6K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.57M | $74.0M | 3.31% | +111.7K | 2026-06-30 |